Emerging Vulnerabilities and Risks in Therapy Manufacture: Cell and Gene Therapy Production as an Emerging Domain of Critical Infrastructure
Cell and gene therapies derive from a substantial manipulation of cells or the application of gene editing techniques. They are promising products because they enable therapy personalisation, are potentially helpful for treating rare or resistant diseases, and may become useful in future epidemics....
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2025-03-01
|
| Series: | European Journal of Risk Regulation |
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S1867299X24000564/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|